Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer [Yahoo! Finance]
Burning Rock Biotech Limited - American Depositary Shares (BNR)
Company Research
Source: Yahoo! Finance
Genesis) and Burning Rock Biotech Limited (NASDAQ: BNR, “Burning Rock”) today announced that the OncoGuide™ OncoScreen™ Plus CDx System based on OncoScreen™ Plus to be used as a companion diagnostic for AstraZeneca's capivasertib has received Manufacturing and Marketing Approval from Japan's Ministry of Health, Labour and Welfare (MHLW). Burning Rock The CDx System is a combination medical device consisting of the OncoGuide™ OncoScreen™ Plus CDx Kit and the OncoGuide™ OncoScreen™ Plus CDx Analysis Program, designed to be used with a next-generation sequencer. It enables the detection of PIK3CA AKT1 , and PTEN alterations in a single test. This diagnostic tool is intended to guide treatment decisions for adult patients with unresectable or recurrent hormone-receptor (HR)-positive, HER2-negative breast cancer who have progressed following endocrine therapy and whose tumors carry one or more PIK3CA AKT1 , or PTEN gene alterations. The approval of this CDx system supports the use fo
Show less
Read more
Impact Snapshot
Event Time:
BNR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNR alerts
High impacting Burning Rock Biotech Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNR
News
- Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025GlobeNewswire
- Burning Rock Reports Third Quarter 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Burning Rock Reports Third Quarter 2025 Financial ResultsGlobeNewswire
- Burning Rock Biotech (NASDAQ:BNR) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=BNR&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StreetMarketBeat
- Multi Cancer Early Detection Testing Market to Reach US$ 7.52 Billion by 2033 as Galleri, CancerSEEK, and Next-Gen Liquid Biopsies Lead Global AdoptionPR Newswire
BNR
Sec Filings
- 12/1/25 - Form 6-K
- 11/20/25 - Form 6-K
- 11/14/25 - Form SCHEDULE
- BNR's page on the SEC website